- Investing Ideas
- Italian Pharmaceuticals & Biotech Pure Equity Growth
Italian Pharmaceuticals & Biotech Pure Equity Growth
Results
2
0 new
Companies that has zero debt on their balance sheet and is forecast to grow at an exponential rate in the future.
2 companies
Krystal Biotech
Market Cap: €8.9b
A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.
1KRYS
€262.60
7D
4.1%
1Y
120.4%
Corcept Therapeutics
Market Cap: €7.9b
A biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
1CORT
€65.06
7D
9.1%
1Y
0.5%